| Product Code: ETC13365692 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Pharmacogenomics Technology Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Pharmacogenomics Technology Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Pharmacogenomics Technology Market Revenues & Volume, 2021 & 2031F |
3.3 North America Pharmacogenomics Technology Market - Industry Life Cycle |
3.4 North America Pharmacogenomics Technology Market - Porter's Five Forces |
3.5 North America Pharmacogenomics Technology Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Pharmacogenomics Technology Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 North America Pharmacogenomics Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 North America Pharmacogenomics Technology Market Revenues & Volume Share, By Testing Method, 2021 & 2031F |
3.9 North America Pharmacogenomics Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 North America Pharmacogenomics Technology Market Revenues & Volume Share, By Market Driver, 2021 & 2031F |
4 North America Pharmacogenomics Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Pharmacogenomics Technology Market Trends |
6 North America Pharmacogenomics Technology Market, 2021 - 2031 |
6.1 North America Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Pharmacogenomics Technology Market, Revenues & Volume, By Genotyping, 2021 - 2031 |
6.1.3 North America Pharmacogenomics Technology Market, Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031 |
6.1.4 North America Pharmacogenomics Technology Market, Revenues & Volume, By Gene Expression Profiling, 2021 - 2031 |
6.1.5 North America Pharmacogenomics Technology Market, Revenues & Volume, By Bioinformatics Solutions, 2020 - 2028 |
6.1.6 North America Pharmacogenomics Technology Market, Revenues & Volume, By Companion Diagnostics, 2020 - 2028 |
6.2 North America Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Pharmacogenomics Technology Market, Revenues & Volume, By Personalized Medicine, 2021 - 2031 |
6.2.3 North America Pharmacogenomics Technology Market, Revenues & Volume, By Drug Response Analysis, 2021 - 2031 |
6.2.4 North America Pharmacogenomics Technology Market, Revenues & Volume, By Oncology Treatment, 2021 - 2031 |
6.2.5 North America Pharmacogenomics Technology Market, Revenues & Volume, By Adverse Drug Reactions, 2021 - 2031 |
6.2.6 North America Pharmacogenomics Technology Market, Revenues & Volume, By Clinical Trials, 2020 - 2028 |
6.3 North America Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Pharmacogenomics Technology Market, Revenues & Volume, By PCR-Based, 2021 - 2031 |
6.3.3 North America Pharmacogenomics Technology Market, Revenues & Volume, By Microarray, 2021 - 2031 |
6.3.4 North America Pharmacogenomics Technology Market, Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031 |
6.3.5 North America Pharmacogenomics Technology Market, Revenues & Volume, By AI-Based Analytics, 2021 - 2031 |
6.3.6 North America Pharmacogenomics Technology Market, Revenues & Volume, By DNA Microarray, 2021 - 2031 |
6.4 North America Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.2 North America Pharmacogenomics Technology Market, Revenues & Volume, By Pharma Companies, 2021 - 2031 |
6.4.3 North America Pharmacogenomics Technology Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.4 North America Pharmacogenomics Technology Market, Revenues & Volume, By Research Labs, 2020 - 2028 |
6.4.5 North America Pharmacogenomics Technology Market, Revenues & Volume, By Academic Institutions, 2020 - 2028 |
6.4.6 North America Pharmacogenomics Technology Market, Revenues & Volume, By Diagnostic Centers, 2020 - 2028 |
6.5 North America Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 North America Pharmacogenomics Technology Market, Revenues & Volume, By Advancements in Precision Medicine, 2020 - 2028 |
6.5.3 North America Pharmacogenomics Technology Market, Revenues & Volume, By Increase in Genetic Testing, 2020 - 2028 |
6.5.4 North America Pharmacogenomics Technology Market, Revenues & Volume, By Growing Interest in Targeted Therapy, 2020 - 2028 |
6.5.5 North America Pharmacogenomics Technology Market, Revenues & Volume, By Expansion in Pharmacovigilance, 2020 - 2028 |
6.5.6 North America Pharmacogenomics Technology Market, Revenues & Volume, By Demand for Tailored Therapeutics, 2020 - 2028 |
7 North America Pharmacogenomics Technology Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.1 United States (US) Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.2 Canada Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.3 Rest of North America Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.3 North America Pharmacogenomics Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
7.3.1 United States (US) Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.2 Canada Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.3 Rest of North America Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 North America Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.4.1 United States (US) Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.4.2 Canada Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.4.3 Rest of North America Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.5 North America Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United States (US) Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Canada Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Rest of North America Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
7.6.1 United States (US) Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
7.6.2 Canada Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
7.6.3 Rest of North America Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
8 North America Pharmacogenomics Technology Market Key Performance Indicators |
9 North America Pharmacogenomics Technology Market - Export/Import By Countries Assessment |
10 North America Pharmacogenomics Technology Market - Opportunity Assessment |
10.1 North America Pharmacogenomics Technology Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Pharmacogenomics Technology Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
10.3 North America Pharmacogenomics Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 North America Pharmacogenomics Technology Market Opportunity Assessment, By Testing Method, 2021 & 2031F |
10.5 North America Pharmacogenomics Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
10.6 North America Pharmacogenomics Technology Market Opportunity Assessment, By Market Driver, 2021 & 2031F |
11 North America Pharmacogenomics Technology Market - Competitive Landscape |
11.1 North America Pharmacogenomics Technology Market Revenue Share, By Companies, 2022 |
11.2 North America Pharmacogenomics Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here